Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia

Archives of Dermatology

Volumn 141, Issue 3, 2005, Pages 368-370

  Ayirookuzhi, Sanjay J ^a   Ma, Li ^a   Ramshesh, Priya ^a   Mills, Glenn ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; IMATINIB; PREDNISONE;

ABDOMINAL PAIN; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DIARRHEA; DISEASE COURSE; DYSPNEA; ERYTHEMA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; SKIN DEFECT; SKIN NODULE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SWEET'S SYNDROME;

EID: 14944383796     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.3.368     Document Type: Article

References (8)

1. Cooper PH, Frierson HF, Greer KE. Subcutaneous neutrophilic infiltrates in acute febrile neutrophilic dermatosis. Arch Dermatol. 1983;119:610-611.
2. Deininger MW, Goldman JM, Lydon N, et al. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL positive cells. Blood. 1997;90:3691-3698.
3. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine-kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031-1037.
4. Kantarjian H, Sawyers S, Hochhaus A, et al; International STI571CML Study Group. Hematologic and cytogenic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002;346:645-652.
5. Drummond A, Micallef-Eynaud P, Douglas WS, et al. A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec). Br J Haematol. 2003;120:911-913.
6. Brouard M, Saurat JH. Cutaneous reactions to STI 571. N Engl J Med. 2001;345:618-619.
7. Hsiao L, Chung H, Lin J, et al. Stevens-Johnson syndrome after treatment with STI571: a case report. Br J Haematol. 2002;117:620-622.
8. Cohen PR, Kurzrock R. Chronic myeloid leukemia and Sweet syndrome. Am J Hematol. 1989;32:134-137.